I spoke today to an MD who worked for the FDA for many years and dealt with compassionate use requests. They are given on a patient by patient request.
Additionally he said the CRO reports to the company and not the FDA. The FDA could only get results from the company itself. If the company has the results and they were good one would think they would release them.
Maybe just maybe doctors who had patients in the study and saw great results have requested Brilacidin for these additional patients even though the study is not technically completed.